Overview

  • Product name
  • Description
    Goat polyclonal to CXXC4
  • Tested applications
    Suitable for: WB, IHC-Pmore details
  • Species reactivity

    Predicted to work with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide:

    C-GTSLERTPVPSAEA

    , corresponding to C terminal (near) amino acids 180-193 of Human CXXC4 (NP_079488.1).

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage buffer
    Preservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris buffered saline, pH 7.3
  • Concentration information loading...
  • Purity
    Immunogen affinity purified
  • Purification notes
    Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • Clonality
    Polyclonal
  • Isotype
    IgG

Applications

Our Abpromise guarantee covers the use of ab99464 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use at an assay dependent dilution. Preliminary experiments in Human brain (cerebellum, hippocampus) lysates gave no specific signal but low background (at antibody concentration up to 1 µg/ml). We would welcome your feedback if you have tested this antibody in more suitable positive controls.
IHC-P Use a concentration of 3 - 5 µg/ml.

Target

Anti-CXXC4 antibody images

  • Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human breast tissue, staining CXXC4 with ab99464 at 3.8 µg/ml.

References for Anti-CXXC4 antibody (ab99464)

ab99464 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab99464.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up